Toad venom is a complex cocktail of bioactive molecules that can stop a dog’s heart within minutes, yet contains compounds now being studied as potential treatments for depression and cancer. Secreted from specialized glands on a toad’s skin, particularly the large parotoid glands behind the eyes, this venom includes two broad classes of chemicals that affect the body in very different ways: cardiac glycosides that interfere with heart rhythm, and tryptamines that act on serotonin receptors in the brain. The gap between “poison” and “medicine” here is razor-thin, and misunderstanding that distinction has killed people.
How Toads Make and Deliver Their Venom
Toads in the family Bufonidae carry a pair of bulging parotoid macroglands on each side of the head, behind the eyes. These glands are not like typical skin glands. Each parotoid is packed with hundreds of individual secretory units arranged in a honeycomb pattern, and each unit is capped by a thick epithelial plug that normally keeps the venom sealed inside. When a predator bites down on a toad, the mechanical pressure forces venom out through a narrow slit in each duct, shooting it as a thin jet directly into the attacker’s mouth.
1PubMed. Structural cutaneous adaptations for defense in toad (Rhinella icterica) parotoid macroglandsThis is entirely a passive defense. Toads do not spray venom voluntarily the way some snakes spit. The system depends on a predator applying force. Research on the South American toad Rhinella jimi showed that after mechanical compression, the venom glands are emptied entirely, and the force from a predator’s bite is enough to generate the pressure needed to expel the venom through those narrow ducts.
2PubMed. Parotoid macroglands in toad (Rhinella jimi): their structure and functioning in passive defenceInside the glands, the secretory layer is a syncytium, meaning the cells share a continuous cytoplasm rather than being walled off from one another. This tissue is loaded with smooth endoplasmic reticulum, the cellular machinery associated with producing the steroid-like toxins that make toad venom so dangerous to the cardiovascular system.
3Toxicon. Morphology of the large granular alveoli of the parotoid glands in toad (Bufo ictericus) before and after compression – Section: AbstractWhat Is Actually in Toad Venom
Toad venom is not a single poison. It contains dozens of compounds, but the ones that matter most for understanding its effects on humans and animals fall into two groups: bufadienolides and tryptamines. These two classes do completely different things to the body, which is why toad venom can simultaneously be a heart toxin and a psychoactive substance.
Bufadienolides
Bufadienolides are steroid compounds that closely resemble the cardiac glycosides found in foxglove, the plant from which the heart drug digoxin was originally derived. They work by blocking the sodium-potassium pump (Na⁺/K⁺-ATPase), an enzyme embedded in cell membranes throughout the body that keeps sodium and potassium levels balanced. When this pump is blocked in heart muscle cells, calcium accumulates inside, causing the heart to contract more forcefully at first but eventually pushing it into dangerous rhythm disturbances.
Different bufadienolides vary enormously in potency. Testing on human kidney cells showed that arenobufagin and bufalin were about 100 times more potent at blocking the sodium-potassium pump than ψ-bufarenogin, a structural cousin with a slightly different chemical skeleton. The hydroxyl group at position C-14 on the molecule appears to be a key factor in how strongly a given bufadienolide can inhibit the pump.
4PubMed. Bufadienolides from parotoid gland secretions of Cuban toad Peltophryne fustiger (Bufonidae): Inhibition of human kidney Na(+)/K(+)-ATPase activityThis structural sensitivity matters because not all toad species produce the same blend of bufadienolides, and the proportion of high-potency to low-potency compounds varies. Some bufadienolides with a C-14 alpha configuration are weak inhibitors across the board, while those with the beta configuration can produce near-total shutdown of the sodium-potassium pump in certain tissues.
5PubMed. Selective inhibition of the cellular sodium pump by emicymarin and 14ß anhydroxy bufadienolidesTryptamines
The second major class of compounds in toad venom consists of tryptamines, molecules structurally related to serotonin. Not all toad species produce significant quantities of tryptamines, but the Sonoran Desert toad (Incilius alvarius) is famous for it. Chemical analysis of this species’ secretions confirmed the presence of 5-MeO-DMT at an average concentration of about 410,000 micrograms per gram of dried secretion, making it far and away the dominant tryptamine in the venom. Bufotenine, DMT, and several other related compounds were also detected, but at concentrations hundreds to thousands of times lower.
6Journal of Analytical Toxicology. Qualitative and Quantitative Analysis of Tryptamines in the Poison of Incilius alvarius (Amphibia: Bufonidae)A separate study analyzing secretions from 26 individual Sonoran Desert toads confirmed that every single animal produced 5-MeO-DMT in both the parotoid and leg gland secretions. Interestingly, the ventral and dorsal skin secretions contained a greater diversity of tryptamine-derived compounds than the parotoid secretions alone, suggesting the toad’s chemical defense is layered across its body surface.
7PLoS One. Diet and chemical defenses of the Sonoran Desert toad5-MeO-DMT and its relatives act on serotonin receptors in the brain, particularly the 5-HT1A and 5-HT2A receptors. Research into the receptor-binding behavior of 5-MeO-DMT derivatives found that all tested compounds displaced radioligand binding at both receptor subtypes at nanomolar concentrations and showed full agonist activity at the 5-HT2A receptor in functional assays.
8PubMed Central. Structure-activity relationships of serotonergic 5-MeO-DMT derivatives: insights into psychoactive and thermoregulatory propertiesTraditional Uses in Chinese Medicine
The oldest documented medicinal use of toad venom comes from traditional Chinese medicine, where a preparation called Chan Su has been used for centuries. Chan Su is made from the dried secretions of toad parotoid glands and has been applied as a topical anesthetic and cardiac medication.
9PubMed. Effects of Chan Su, a traditional Chinese medicine, on the calcium transients of isolated cardiomyocytes: cardiotoxicity due to more than Na, K-ATPase blockingSince the 1980s, Chan Su has also been used clinically in China as an anticancer agent. Its active components, including bufalin, cinobufagin, and several related bufadienolides, have shown activity against multiple cancer types in laboratory settings, including breast cancer, colorectal cancer, liver cancer, and esophageal cancer.
10PubMed Central. A research update on the antitumor effects of active components of Chinese medicine ChanSuChan Su is also the preparation behind most toad-venom poisoning cases reported in medical literature. It sometimes shows up in products marketed as aphrodisiacs or herbal remedies outside the context of traditional Chinese medicine, and people who take it without understanding what they’re ingesting can end up in cardiac arrest.
Modern Research on Cancer
The anticancer properties of bufalin, one of the most potent bufadienolides in toad venom, have attracted sustained interest from cancer researchers. Lab studies have shown that bufalin can trigger programmed cell death in cancer cells through more than one pathway. In glioma cells (a type of brain cancer), bufalin induced the standard form of programmed cell death (apoptosis), and when the cancer cells attempted to evade that mechanism, bufalin triggered an alternative form of cell death called necroptosis instead.
11PubMed Central. Bufalin Induces Glioma Cell Death by Apoptosis or NecroptosisIn gastric cancer cells, bufalin’s effects were concentration-dependent. At low concentrations, it halted cell division by arresting cells in the middle of mitosis. At higher concentrations, it pushed cells into apoptosis outright. The mechanism involved shifting the balance between pro-survival and pro-death signaling proteins and transiently activating then completely shutting down a key cell-survival pathway.
12PubMed. PI3K/Akt is involved in bufalin-induced apoptosis in gastric cancer cellsThe gap between lab results and clinical medicine remains wide, however. Bufalin kills cancer cells in a dish at very low concentrations, but that is true of many compounds that never become drugs. The same sodium-potassium pump inhibition that makes bufalin effective against cancer cells also makes it dangerously toxic to heart muscle. Translating these findings into treatments that kill tumors without killing the patient is the central challenge, and no bufadienolide-based drug has been approved for cancer treatment outside of traditional Chinese medicine practice.
Psychiatric Research on 5-MeO-DMT
The psychoactive tryptamines in toad venom, particularly 5-MeO-DMT, have drawn interest as potential treatments for depression. The first phase 2a clinical trial testing intranasal 5-MeO-DMT alongside standard antidepressants (SSRIs) in patients with treatment-resistant depression reported encouraging early results. In the group receiving a 10-milligram dose, two-thirds of participants showed at least a 50% reduction in depression scores within two days, and five out of six maintained that response at 85 days after a single dose.
13PubMed Central. Intranasal 5-MeO-DMT Concomitant with SSRI for Treatment-Resistant Depression: A Proof-of-Concept TrialThis is genuinely promising, but it needs context. The trial enrolled only 12 participants total across two dosing groups, there was no placebo arm, and the results are best described as proof-of-concept rather than proof of efficacy. The pharmaceutical compound used in this trial was a synthetic, purified version of 5-MeO-DMT, not toad secretion. That distinction matters enormously: dried toad secretion contains a chaotic mixture of bufadienolides and tryptamines at variable concentrations, and the cardiac toxins present alongside the psychoactive ones can kill.
Analysis of dried Sonoran Desert toad secretion found that 5-MeO-DMT made up roughly 25 to 30% of the material by weight. Practitioners who administer vapor from dried toad secretion in ceremonial settings typically use 20 to 120 milligrams of dried material, meaning a person inhaling a 30-milligram dose might receive about 7.5 to 9 milligrams of 5-MeO-DMT, while someone given 120 milligrams might take in 30 to 36 milligrams. Those higher doses far exceed what has been tested in controlled medical settings, and the co-ingestion of bufadienolides adds unpredictable cardiac risk that simply does not exist with pharmaceutical-grade 5-MeO-DMT.
How Toad Venom Kills People
The clinical picture of toad venom poisoning looks strikingly similar to digoxin overdose, because the underlying mechanism is the same: sodium-potassium pump blockade in the heart. A review of 36 toad poisoning cases found that almost all patients initially developed gastrointestinal symptoms like nausea, vomiting, and abdominal pain. About a third presented with bradycardia (abnormally slow heart rate), and roughly one in five had dangerously low blood pressure on arrival. Electrocardiograms showed sinus bradycardia in the majority of those with rhythm disturbances, with occasional complete heart block or atrial fibrillation.
14PubMed Central. Toad Poisoning: Clinical Characteristics and OutcomesThree patients in that series went into cardiac arrest, and two of those arrests happened within hours of ingestion. Serum digoxin assays, which cross-react with bufadienolides, registered positive in most tested patients. The highest reading was above 8 nanograms per milliliter, found in a patient who died. Most survivors were hospitalized for about two days.
14PubMed Central. Toad Poisoning: Clinical Characteristics and OutcomesA separate case report described a healthy man who developed severe, unrelenting bradycardia, dangerously elevated potassium levels, and metabolic acidosis after taking pills marketed as an aphrodisiac. He progressed rapidly to life-threatening cardiac arrhythmias and died within hours. The pills turned out to contain toad venom.
15PubMed Central. Toad venom poisoning: resemblance to digoxin toxicity and therapeutic implicationsBecause toad venom toxicity mimics digoxin poisoning, the same antidote used for digoxin overdose has shown effectiveness. Digoxin-specific antibody fragments (marketed as Digibind) were tested in mice poisoned with Chan Su extract. All 30 untreated mice died after developing seizures, while only 7 out of 15 treated mice died, a result that was highly statistically significant. These antibody fragments are now recommended in clinical guidance for suspected toad venom ingestion.
16PubMed. Efficacy of digoxin specific Fab fragments (Digibind) in the treatment of toad venom poisoningThe Danger to Dogs
Toad venom poisoning is far more common in dogs than in humans, particularly in regions where large toxic toad species like Rhinella marina (the cane toad) are present. Dogs encounter toads by mouthing or biting them, which compresses the parotoid glands and delivers venom directly to the oral mucosa, where absorption is rapid.
Veterinary guidance emphasizes that the single most important step is rinsing the dog’s mouth immediately. If the owner witnesses the encounter and the dog is conscious, they should flush the mouth with water from a garden hose, directing the spray from the corner of the mouth forward and keeping the dog’s head tilted down to prevent aspiration. If the dog is already having seizures, mouth rinsing should be done by a veterinarian with airway protection in place.
17Journal of the American Animal Hospital Association. Toad Intoxication in the Dog by Rhinella marina: The Clinical Syndrome and Current Treatment Recommendations – Section: TreatmentSpeed matters here. The bufadienolides absorb quickly across mucous membranes, and dogs can progress from drooling and pawing at their mouths to seizures, cardiac arrhythmias, and death within 15 to 30 minutes in severe cases. In areas where cane toads are established, veterinary emergency clinics see spikes in toad poisoning cases during the warm, wet months when toads are most active.
Ecological Fallout From Toad Toxins
Toad venom is not just a medical concern for humans and pets; it has reshaped entire ecosystems. The cane toad, introduced to Australia in 1935, provides the most dramatic example. As cane toads have spread across northern and eastern Australia, native predators that attempt to eat them have been devastated.
A comprehensive review found that lethal toxic ingestion is the primary mechanism of impact. Populations of large predatory lizards, certain snake species, freshwater crocodiles, and carnivorous marsupials have all been hit, though the severity varies among species and across different regions.
18PubMed. The ecological impact of invasive cane toads (Bufo marinus) in AustraliaField data from southern Australia showed that populations of land mullets, eastern water dragons, lace monitors, and red-bellied black snakes were 84 to 100% lower in areas where cane toads had established themselves compared to toad-free zones. The loss of scavenging lace monitors alone reduced carrion removal rates by about half and triggered a 61% increase in brush turkey numbers, demonstrating how removing a predator from the food web can cascade unpredictably.
19PubMed Central. The impact of invasive cane toads on native wildlife in southern AustraliaIn northern Australia, three species of monitor lizards suffered severe declines after cane toads arrived. Water monitor populations dropped by roughly 50% over five years spanning the toad invasion front. With fewer monitors raiding nests, fledging success of the crimson finch jumped from 55% to 81%. The overall pattern is one of predators losing control of their prey populations, reshuffling animal densities across the savannah ecosystem.
20PubMed. Invasive toads shift predator-prey densities in animal communities by removing top predatorsHow Some Predators Evolved Resistance
The flip side of toad venom’s ecological destructiveness is the evolutionary arms race it has driven. In regions where toads have been present for millions of years, some predators have evolved resistance to bufadienolides through remarkably specific genetic changes. A large-scale study found that resistance to cardiac glycosides across insects, amphibians, reptiles, and mammals comes down to similar molecular alterations in the same enzyme the toxins target: the sodium-potassium pump itself. Across all these groups, just two of the twelve amino acids making up the core binding site for cardiac glycosides have been repeatedly swapped out, reducing the toxin’s ability to latch on.
21PubMed Central. Widespread convergence in toxin resistance by predictable molecular evolutionIn toad-feeding reptiles, this resistance has evolved independently at least four times, driven by the same pair of point mutations. Even more telling, varanid lizards (monitors) that migrated to toad-free areas show molecular evidence of reverting back to the susceptible version of the enzyme, suggesting that carrying the resistance mutations comes with a fitness cost when you don’t need them. This kind of convergent evolution, where unrelated animals arrive at the same solution to the same chemical problem, is one of the cleaner demonstrations in biology that natural selection can be highly predictable at the molecular level.
21PubMed Central. Widespread convergence in toxin resistance by predictable molecular evolutionThis research also helps explain why Australia’s native predators have been so vulnerable. They evolved without exposure to bufonid toads and lack the protective mutations that toad-feeding species elsewhere carry. Their sodium-potassium pumps are fully susceptible, meaning even a single mouthing of a cane toad can deliver a lethal dose of bufadienolides.
Bufotenine in the Human Body
One of the stranger facts about toad venom chemistry is that humans naturally produce some of the same molecules. Bufotenine, the tryptamine found in toad secretions alongside 5-MeO-DMT, has been detected in human urine, and an enzyme called indolethylamine N-methyltransferase (INMT) that synthesizes it from serotonin is widely distributed in non-neural human tissues. A study measuring bufotenine levels in human biological samples found large amounts in stool, suggesting a possible role in intestinal function that remains poorly understood.
22PubMed. Potentially hallucinogenic 5-hydroxytryptamine receptor ligands bufotenine and dimethyltryptamine in blood and tissuesBufotenine is not just an idle metabolic byproduct. Testing on cardiac tissue from transgenic mice expressing human serotonin receptors showed that bufotenine increased the force of heart contractions through stimulation of 5-HT4 serotonin receptors, and this effect was confirmed in human atrial tissue preparations as well. The compound increased contractile force in a concentration-dependent manner, and the effect could be blocked by a serotonin receptor antagonist.
23PubMed Central. Cardiovascular effects of bufotenin on human 5-HT4 serotonin receptors in cardiac preparations of transgenic mice and in human atrial preparationsWhat endogenous bufotenine actually does in the human gut and whether its levels fluctuate in any meaningful way remain open questions. But the fact that our bodies produce a compound identical to one found in toad venom underscores an important point: many “exotic” toxins are variations on molecules that already circulate in mammalian biology. The difference between a signaling molecule and a poison is often just concentration.